AI Verdict
MBBC has stronger fundamentals based on our AI analysis.
MBBC vs MAZE Fundamental Comparison
| Metric | MBBC | MAZE |
|---|---|---|
| Revenue | $5.8M | $0.0 |
| Net Income | $945,689.0 | $-131.1M |
| Net Margin | 16.2% | N/A |
| ROE | 2.0% | -36.9% |
| ROA | 0.4% | -33.0% |
| Current Ratio | N/A | 15.50x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $0.35 | $-3.05 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MBBC vs MAZE: Frequently Asked Questions
Is MBBC or MAZE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MBBC has stronger fundamentals. MBBC is rated HOLD (60% confidence) while MAZE is rated SELL (84% confidence). This is not investment advice.
How does MBBC compare to MAZE fundamentally?
Marathon Bancorp, Inc. /MD/ has ROE of 2.0% vs Maze Therapeutics, Inc.'s -36.9%. Net margins are 16.2% vs N/A respectively.
Which stock pays higher dividends, MBBC or MAZE?
MBBC has a dividend yield of N/A or no dividend while MAZE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MBBC or MAZE for long term?
For long-term investing, consider that MBBC has HOLD rating with 60% confidence, while MAZE has SELL rating with 84% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MBBC vs MAZE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MBBC vs MAZE, the AI consensus favors MBBC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.